Moomoo AIのまとめ
Blake Borgeson, a reporting person associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 20,054 shares of Class A Common Stock on March 19, 2024. The shares were sold at a price of $10.792 per share, resulting in a total transaction value of approximately $216,422.77. Following the sale, Borgeson's direct holdings in the company amount to 7,252,755 shares. The transaction was executed in the open market and is part of the normal course of trading activities.
Blake Borgeson, a reporting person associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 20,054 shares of Class A Common Stock on March 19, 2024. The shares were sold at a price of $10.792 per share, resulting in a total transaction value of approximately $216,422.77. Following the sale, Borgeson's direct holdings in the company amount to 7,252,755 shares. The transaction was executed in the open market and is part of the normal course of trading activities.
Recursion Pharmaceuticals, Inc. [RXRX]に関連する報告書の作成者Blake Borgesonは、2024年3月19日に普通株式クラスAの20,054株を$10.792の価格で売却し、約$216,422.77の取引価値を得ました。売却後、ボーゲソンの直接保有する株式数は7,252,755株となります。この取引は市場で実行され、取引活動の通常の一環です。
Recursion Pharmaceuticals, Inc. [RXRX]に関連する報告書の作成者Blake Borgesonは、2024年3月19日に普通株式クラスAの20,054株を$10.792の価格で売却し、約$216,422.77の取引価値を得ました。売却後、ボーゲソンの直接保有する株式数は7,252,755株となります。この取引は市場で実行され、取引活動の通常の一環です。
役に立った
役に立たない